GUTS Fractyl Health Inc.

Price (delayed)

$0.713

Market cap

$113.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.29

Enterprise value

$110.77M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 2

We are a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. Despite advances in treatment over the last ...

Highlights
Fractyl Health's equity has soared by 126% from the previous quarter
The EPS is up by 31% since the previous quarter and by 31% year-on-year
GUTS's quick ratio has soared by 83% year-on-year but it is down by 8% since the previous quarter
The company's net income rose by 23% QoQ but it fell by 21% YoY
GUTS's gross profit has dropped by 100% year-on-year
The revenue has dropped by 100% year-on-year

Key stats

What are the main financial stats of GUTS

GUTS stock price

How has the Fractyl Health stock price performed over time
Intraday
-6.18%
1 week
-15.22%
1 month
-1.94%
1 year
-63.81%
YTD
-67.59%
QTD
55.74%

Financial performance

How have Fractyl Health's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$92.88M
Net income
-$108M
Gross margin
N/A
Net margin
N/A
GUTS's gross profit has dropped by 100% year-on-year
The revenue has dropped by 100% year-on-year
The company's net income rose by 23% QoQ but it fell by 21% YoY
The company's operating income rose by 4.1% QoQ and by 4% YoY

Price vs fundamentals

How does GUTS's price correlate with its fundamentals

Growth

What is Fractyl Health's growth rate over time

Valuation

What is Fractyl Health stock price valuation
P/E
N/A
P/B
5.29
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 31% since the previous quarter and by 31% year-on-year
Fractyl Health's equity has soared by 126% from the previous quarter
The revenue has dropped by 100% year-on-year

Efficiency

How efficient is Fractyl Health business performance
The ROA has contracted by 42% YoY but it has grown by 27% from the previous quarter
GUTS's return on invested capital is down by 30% year-on-year but it is up by 23% since the previous quarter

Dividends

What is GUTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GUTS.

Financial health

How did Fractyl Health financials performed over time
Fractyl Health's total assets is 27% higher than its total liabilities
GUTS's quick ratio has soared by 83% year-on-year but it is down by 8% since the previous quarter
The current ratio has soared by 71% YoY but it fell by 10% QoQ
GUTS's debt is 184% greater than its equity
Fractyl Health's equity has soared by 126% from the previous quarter
Fractyl Health's debt to equity has shrunk by 71% YoY and by 56% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.